Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. 1 However, the early onset of HCC is difficult to identify, and tumors are often found in the later stages of the disease. 2, 3 Many studies have demonstrated that the occurrence of HCC is closely related to the dysregulation of multiple genes and key signaling pathways. 4, 5 Therefore, it is important to study the molecular mechanisms 
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Yue et al of HCC carcinogens to help us explore more effective tumor markers for early detection and key therapeutic targets of HCC. MicroRNAs are predicted to control the activity of about 50% of all protein-coding genes, and deregulated miRNA expression has been implicated in a variety of cancers. 6, 7 Accumulating evidence suggests that lncRNAs play important roles in the regulation of cell proliferation, invasion, and angiogenesis through interactions with miRNAs and mRNAs. [8] [9] [10] The competing endogenous RNA (ceRNA) hypothesis was proposed, which revealed how mRNAs and lncRNAs "talk" to each other using miRNA response elements as letters of a new language, and how ceRNA activity forms a large-scale regulatory network across the transcriptome. 11 The interaction between lncRNAs and mRNAs through shared miRNAs represents a novel layer of gene regulation that plays important roles in the physiology and development of cancer. 12 However, studies of lncRNAmiRNA-mRNA ceRNA regulatory networks in HCC based on multiple databases have rarely been reported.
In this study, we integrated expression data from multiple databases and screened out potential prognostic genes in HCC by bioinformatic analysis. Then, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway-enrichment analysis was performed to help us understand the molecular mechanisms underlying the development of HCC. Subsequently, we constructed a ceRNA regulatory network to clarify potential relationships among lncRNAs, miRNAs, and mRNAs. Moreover, expression levels of key potential prognostic genes in the ceRNA regulatory network were validated using quantitative realtime (qRT) PCR analysis. In summary, our study not only identified potential molecular markers for the early diagnosis and prognosis of HCC but also provides new insights into HCC-interventional strategies.
Methods

gene-expression data
Five gene-expression-profile groups (GSE14520, GSE17548, GSE19665, GSE29721, and GSE60502) were downloaded from the Gene Expression Omnibus (GEO) database (https:// www.ncbi.nlm.nih.gov/geo) from a total of 79 HCC-tissue and 77 adjacent normal liver-tissue samples. Information about the five groups of GEO datasets is shown in Table 1 . Whole-transcriptome sequencing (WTS) data of 374 HCC-tissue and 50 adjacent normal liver-tissue samples and clinical data of 374 HCC patients were downloaded from the Cancer Genome Atlas (TCGA) database (http:// cancergenome.nih.gov).
screening for differentially expressed genes using integrated bioinformatic analysis Data of the gene-expression profiles (GSE14520, GSE17548, GSE19665, GSE29721, and GSE60502) were calibrated, standardized, and log 2 -transformed after being processed using the R software package. Differential expression analysis between HCC and adjacent normal liver tissue was performed using R software with the Limma package. Log 2 fold change (FC) .1 and P,0.05 were used as cutoff criteria. Subsequently, lists of differentially expressed genes (DEGs) obtained from the differential expression analysis of the five GEO-microarray data-set groups were integrated using R software with the RRA (robust rank aggregation) package, which is openly available on the comprehensive R network (http://cran.r-project.org) and based on the hypothesis that each gene is randomly ordered in each experiment and that there is a greater likelihood of differential gene expression when a gene is ranked high in all experiments. P,0.05 was used as the cutoff criterion.
RNA-sequencing data downloaded from the TCGA database was organized into gene-expression-matrix files. Protein-coding mRNA-and lncRNA-expression data were separated from the RNA-sequencing data, and the extracted data were used without further transformation. Differential mRNA expression was analyzed in HCC-tissue and adjacent normal liver-tissue samples with the R software with the Limma package. Log 2 FC .1 and P,0.05 were used as cutoff criteria.
Kaplan-Meier curve analysis
Kaplan-Meier curve analysis was performed on the DEGs in HCC-tissue samples compared with adjacent normal liver tissue to obtain potential prognostic genes that were significantly associated with HCC patient prognoses, based 
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screening for differentially expressed genes from geO and Tcga databases
A total of 854, 348, 2,120, 820, and 1,052 DEGs were screened from the GSE14520, GSE17548, GSE19665, GSE29721, and GSE60502 data sets, respectively. The differential expression of multiple genes from the two sets of data included in each of the five microarrays is shown in Figure S1 , and cluster heat maps of the top-50 DEGs are shown in Figure S2 . A total of 429 DEGs were screened using RRA analysis, including 150 upregulated and 279 downregulated genes. The heat map of the top-20 upregulated and downregulated genes is shown in Figure 1 . Differential expression analyses of protein-coding mRNAs in HCC-tissue and adjacent normal liver-tissue samples from the TCGA data sets were performed using R with Limma package (Log 2 FC .1 and P,0.05). A total of 4,844 DEGs were identified, including 3,756 upregulated and 1,088 downregulated mRNAs. DEG volcano plots and cluster heat maps are shown in Figure 2 .
Identification of potential prognostic genes
The Venn online tool (http://bioinformatics.psb.ugent. be/webtools/Venn) was used to screen 369 genes, which were differentially expressed in HCC tissue samples compared with adjacent normal liver tissue samples from both the TCGA database and the five GEO database groups. Kaplan-Meier curve analysis was performed on the DEGs from the downloaded clinical data and the standardized gene-expression-matrix files, which were derived from the TCGA data set using R software with the survival package (P,0.05). Finally, a total of 152 potential prognostic genes were screened out, consisting of 86 upregulated genes and 66 downregulated genes, which were differentially expressed in HCC tissue compared with adjacent normal liver tissue and submit your manuscript | www.dovepress.com
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gO and Kegg pathway-enrichment analyses
The DAVID online tool was used to analyze functional and pathway-enrichment to investigate the function of potential prognostic genes. Significant results regarding the GO enrichment analyses of potential prognostic genes are shown in Figure S3 . The GO analysis divided potential prognostic genes into three functional groups: molecular function, biological process, and cell composition. In the biological process group, potential prognostic genes were primarily enriched in cell division, mitotic nuclear division, sisterchromatid cohesion, and mitotic spindle organization. In the cell-composition group, potential prognostic genes were mainly enriched in mid-body formations, condensed chromosome kinetochores, and spindle poles. In the molecular function group, potential prognostic genes were mainly enriched in microtubule binding, microtubule-motor activity, and monooxygenase activity. KEGG signaling pathways of potential prognostic genes were mainly enriched in factors 
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cerna regulatory network for hcc development associated with the cell cycle, metabolic pathways, retinol metabolism, arachidonic acid metabolism, the p53-signaling pathway, oocyte meiosis, chemical carcinogenesis, drug metabolism, the CYP/CYP450 pathway, complement and coagulation cascades, linoleic acid metabolism, and HTLV1 infection, as shown in Table 3 and Figure S4 .
Identification of differentially expressed mirnas and lncrnas
A total of 126 DEMs were identified, including 123 upregulated and three downregulated miRNAs. Additionally, 1,059
DELs were identified, including 1,002 upregulated and 57 downregulated lncRNAs. Heat maps and volcano plots of the DEMs and DELs are shown in Figure 3 .
construction of competing endogenous rna regulatory network
We found a total of 13 key potential prognostic genes whose expression might be affected by the eight DEMs. Meanwhile, the functions of these eight DEMs were predicted to be regulated by 61 DELs. Interactions among DELs, DEMs, and the key potential prognostic genes are listed in Table 4 . Notes: Protein-encoding mrna-expression data were screened and analyzed using r software and the limma package. log 2 Fc .1 and P,0.05 were used as cutoff criteria. Abbreviations: Fc, fold change; Tcga, the cancer genome atlas; hcc, hepatocellular carcinoma; WTs, whole-transcriptome sequencing; FDr, false discovery rate. 
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The network of gene nodes and interactions were visualized using the Cytoscape software, as shown in Figure 4 . Kaplan-Meier curve analyses were performed on the miRNAs and lncRNAs in the ceRNA regulatory network based on the HCC-patient clinical data from the TCGA database. Nine key candidate lncRNAs (AL163952.1, AL359878.1, AP002478.1, C2orf48, C10orf91, CLLU1, CLRN1-AS1, ERVMER61-1, and WARS2-IT1) were significantly associated with HCC-patient prognoses, as shown in Figure 5 . However, no DEMs were identified in the ceRNA regulatory network related to the postoperative survival of HCC patients.
Validation of key potential prognostic genes by quantitative real-time polymerase chain reaction
The key potential prognostic genes were subjected to qRT-PCR on 20 pairs of tissue samples. As shown in Figure 6 , expression levels of eleven genes (CCNB1, CEP55, CHEK1, EZH2, KPNA2, LRRC1, PBK, RRM2, SLC7A11, SUCO, and ZWINT) were upregulated and those of two mRNAs (ACSL1, CDC37L1) downregulated in HCC tissue compared with adjacent normal liver tissue. (P,0.05). Dysregulation trends were consistent with the results of our previous bioinformatic analysis.
Discussion
HCC is one of the leading causes of death worldwide, and is an overwhelming experience for patients, due to its poor prognosis. 13 Therefore, exploring the underlying mechanisms and identifying effective prognostic biomarkers for the early detection of and effective therapy for HCC patients has become an urgent mandate.
Several studies have revealed that some dysregulated genes might act as potential biomarkers in HCC. However, previous studies mainly focused on different gene data without clinical data to predict prognosis in HCC. 4, 14 Several previous studies containing prognostic analyses were mostly based on a single database. 15, 16 In the present study, we screened and integrated the DEGs of five groups of geneexpression data from the GEO database, and then validated these DEGs based on gene expression and clinical survival data from the TCGA database, which could determine more reliable and accurate potential prognostic genes in HCC. This finding provided numerous potential biomarkers which may be used in diagnosing HCC and predicting patient prognoses with HCC. Considering that these potential prognostic genes are the implementers of molecular function, GO and KEGG pathway-enrichment analyses were performed to help us understand the molecular mechanisms underlying the development of HCC. Remarkably, our study reveals that the cell cycle was the most affected pathway in HCC, which may guide individualized therapy choices.
Currently, cross talk is thought to occur between lncRNAs, miRNAs, and mRNAs during many aspects of tumorigenesis, and the ceRNA hypothesis has been considered a novel measure of gene regulation at the posttranscriptional level in multiple tumor types. [17] [18] [19] This study attempted to construct a lncRNA-miRNA-mRNA ceRNA regulatory network during HCC tumorigenesis at the transcriptional level using comprehensive analysis. To confirm the reliability of the ceRNA Notes: mirna-and lncrna-expression data were downloaded and analyzed using r software and the limma package. log 2 Fc .2 and P,0.01 were used as cutoff criteria. Abbreviations: DeMs, differentially expressed mirnas; Dels, differentially expressed lncrnas; Fc, fold change; Tcga, the cancer genome atlas; hcc, hepatocellular carcinoma; WTs, whole-transcriptome sequencing.
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cerna regulatory network for hcc development Figure 5 Kaplan-Meier curve analysis was performed on the Dels in the cerna regulatory network. P,0.05 was used as the cutoff criterion. Abbreviations: Dels, differentially expressed lncrnas; cerna, competing endogenous rna.
regulatory network, differentially expressed miRNAs and lncRNAs were selected, and potential prognostic genes that did not show target DEMs and DELs were deleted. In this study, 13 key potential prognostic genes were included to develop the novel ceRNA network, the expression of which might be regulated by eight DEMs and 61 DELs. We conducted qRT-PCR experiments on 20 pairs of HCCand adjacent liver-tissue samples, and the result showed that expression levels of the 13 key potential prognostic genes were consistent with the result of our previous analysis. Among these key potential prognostic genes, CCNB1, 28 and ZWINT 29 have been validated as oncogenes in HCC according to previous studies. Interestingly, no studies have reported a relationship between SUCO gene expression and tumorigenesis, and we are planning to conduct experiments to explore the role of SUCO in the development and progression of HCC. It has been reported that ACSL1 was upregulated by HBXIP in breast cancer tissue and might play crucial roles in breast cancer development. 30 However, studies regarding the relationship between ACSL1 gene expression and HCC were not reported. In this study, we found that ACSL1 was downregulated in HCC tissues and that patients with high ACSL1 gene expression had a better prognosis, which needs further verification. Another study showed that patients with hepatitis B-associated HCC had higher CDC37L1 gene expression compared with patients without HCC, and CDC37L1 was able to protect HCC patients from persistent drug toxicity. 31 In contrast, we found that the CDC37L1 gene was downregulated in HCC tissue compared with adjacent normal liver tissue based on bioinformatic analyses and qRT-PCR experiments.
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Yue et al Recently, dysregulated miRNAs were reported to be associated with many molecular pathways in tumor evolution and progression. [32] [33] [34] In this ceRNA network, eight DEMs were identified as core elements by which mRNAs and lncRNAs can "talk" to each other in the physiology and development of HCC. The identified DEMs were miR183, 35 41 and miR519d, 42 which have been validated previously to play specific roles in HCC tumorigenesis. These DEMs, which were experimentally validated in previous studies, could ensure ceRNA-network stability and were more conducive to the identification of DELs in this study.
Plenty of studies have certified that lncRNAs could be involved in many functional aspects associated with tumor evolution and progression. [43] [44] [45] In this novel ceRNA network, nine potential prognostic lncRNAs were identified through survival analyses that could participate in the development of HCC. CLLU1 expression was shown to be upregulated in chronic lymphocytic leukemia and has been used for prognostic and diagnostic purposes. 46, 47 It has been reported that AP002478.1 can function as a prognostic biomarker in patients with Helicobacter pylori-positive gastric cancer. 48 Also, C2orf48 and C10orf91 are related to the overall survival time of patients with oral squamous-cell carcinoma. 49 However, lncRNAs CLLU1, AP002478.1, C2orf48, and C10orf91 have not previously been reported in other tumor types, including HCC. Moreover, little is known about the other five potential prognostic lncRNAs (AL163952.1, AL359878.1, CLRN1-AS1, ERVMER61-1, and WARS2-IT1). Therefore, further investigations are needed to clarify the function of these potential prognostic lncRNAs in HCC and other cancers.
Several limitations of the current study should be discussed. First, no DEMs related to postoperative HCCpatient survival were identified in the novel ceRNA network. Second, we lacked the experimental validation of lncRNA and miRNA expression in tissue samples to confirm our findings. Therefore, further research is needed to verify our study findings and unravel the mechanism of ceRNA in HCC.
Conclusion
This study provides numerous potential prognostic genes, and the function and signaling pathways they participate in are presented systematically. Moreover, we constructed a lncRNA-miRNA-mRNA ceRNA regulatory network in HCC, which has important clinical significance for the early detection and diagnosis of HCC and for the potential development of therapeutic targets for HCC. However, further biological experiments are needed to assess the function of these potential prognostic genes and the effect of the miRNAs and lncRNAs present within the ceRNA regulatory network.
